Management of Pregnancy and Survival of Infants with Trisomy 13 or Trisomy 18

Abstract

Objective The objective of this study was to describe antenatal/intrapartum management and survival of liveborn infants with known trisomy 13 (T13) or trisomy 18 (T18) based on planned neonatal care.

Study Design This is a retrospective cohort study of singleton pregnancies complicated by T13/T18 at a tertiary center from 2004 to 2015. We included pregnancies with antenatal or neonatal cytogenetic T13/T18 diagnosis and excluded those which were terminated or had a fetal demise < 20 weeks. We compared antenatal/intrapartum management and neonatal survival by planned neonatal care, defined as either neonatal intervention (INT), including neonatal cardiopulmonary resuscitative measures or comfort care (CC) without resuscitative measures.

Results In this study, 32 women (10 with T13 and 22 with T18) met study criteria; 12 (38%) elected INT and 20 (62%) CC. Compared with those who elected INT, women who elected CC were more likely to undergo elective induction (40 vs. 0%, p = 0.01), have an intrapartum stillbirth (0 vs. 32%, p = 0.14), and deliver vaginally (25 vs. 63%, p < 0.01). In neonatal survival analysis (n = 26), median survival was longer in the INT group compared with CC group (64 days [interquartile range, IQR: 2, 155) vs. 3 days [IQR]: 0.3, 42), p = 0.28), but survival to hospital discharge was similar (53 vs. 57%, p = 0.95).

Conclusion Regardless of desired level of neonatal INT, many women who continue pregnancies complicated by T13/18 have infants who survive beyond hospital discharge.

Keywords

trisomy 13 - trisomy 18 - antenatal testing - neonatal intervention - survival

Note

This material was presented in poster format at the Society for Maternal-Fetal Medicine's Pregnancy Meeting, Atlanta, Georgia, February 2016.

• References

• 1 Mathews TJ, Hamilton BE. First births to older women continue to rise. NCHS Data Brief 2014; (152) 1-8
• 2 Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Mathews TJ. Births: final data for 2011. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics. Natl Vital Stat Rep 2013; 62 (1) 1-69
• 3 Mai CT, Kucik JE, Isenburg J , et al; National Birth Defects Prevention Network. Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006 to 2010: featuring trisomy conditions. Birth Defects Res A Clin Mol Teratol 2013; 97 (11) 709-725
• 4 Irving C, Richmond S, Wren C, Longster C, Embleton ND. Changes in fetal prevalence and outcome for trisomies 13 and 18: a population-based study over 23 years. J Matern Fetal Neonatal Med 2011; 24 (1) 137-141
• 5 Lin HY, Lin SP, Chen YJ , et al. Clinical characteristics and survival of trisomy 18 in a medical center in Taipei, 1988-2004. Am J Med Genet A 2006; 140 (9) 945-951
• 6 Maeda J, Yamagishi H, Furutani Y , et al. The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan. Am J Med Genet A 2011; 155A (11) 2641-2646
• 7 Subramaniam A, Jacobs AP, Tang Y , et al. Trisomy 18: a single-center evaluation of management trends and experience with aggressive obstetric or neonatal intervention. Am J Med Genet A 2016; 170 (4) 838-846
• 8 Guon J, Wilfond BS, Farlow B, Brazg T, Janvier A. Our children are not a diagnosis: the experience of parents who continue their pregnancy after a prenatal diagnosis of trisomy 13 or 18. Am J Med Genet A 2014; 164A (2) 308-318
• 9 Niedrist D, Riegel M, Achermann J, Schinzel A. Survival with trisomy 18—data from Switzerland. Am J Med Genet A 2006; 140 (9) 952-959
• 10 Wu J, Springett A, Morris JK. Survival of trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome) in England and Wales: 2004-2011. Am J Med Genet A 2013; 161A (10) 2512-2518
• 11 Burke AL, Field K, Morrison JJ. Natural history of fetal trisomy 18 after prenatal diagnosis. Arch Dis Child Fetal Neonatal Ed 2013; 98 (2) F152-F154
• 12 Lakovschek IC, Streubel B, Ulm B. Natural outcome of trisomy 13, trisomy 18, and triploidy after prenatal diagnosis. Am J Med Genet A 2011; 155A (11) 2626-2633
• 13 Morris JK, Savva GM. The risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18. Am J Med Genet A 2008; 146A (7) 827-832
• 14 Vonnahme KA, Hess BW, Hansen TR , et al. Maternal undernutrition from early- to mid-gestation leads to growth retardation, cardiac ventricular hypertrophy, and increased liver weight in the fetal sheep. Biol Reprod 2003; 69 (1) 133-140
• 15 Houlihan OA, O'Donoghue K. The natural history of pregnancies with a diagnosis of trisomy 18 or trisomy 13; a retrospective case series. BMC Pregnancy Childbirth 2013; 13: 209
• 16 Rosa RF, Rosa RC, Lorenzen MB , et al. Trisomy 18: experience of a reference hospital from the south of Brazil. Am J Med Genet A 2011; 155A (7) 1529-1535
• 17 Embleton ND, Wyllie JP, Wright MJ, Burn J, Hunter S. Natural history of trisomy 18. Arch Dis Child Fetal Neonatal Ed 1996; 75 (1) F38-F41
• 18 David TJ, Glew S. Morbidity of trisomy 18 includes delivery by caesarean section. Lancet 1980; 2 (8207) 1295
• 19 Young ID, Cook JP, Mehta L. Changing demography of trisomy 18. Arch Dis Child 1986; 61 (10) 1035-1036
• 20 Barry SC, Walsh CA, Burke AL, McParland P, McAuliffe FM, Morrison JJ. Natural history of fetal trisomy 13 after prenatal diagnosis. Am J Med Genet A 2015; 167A (1) 147-150
• 21 Meyer RE, Liu G, Gilboa SM , et al; National Birth Defects Prevention Network. Survival of children with trisomy 13 and trisomy 18: a multi-state population-based study. Am J Med Genet A 2016; 170 (4) 825-837
• 22 Vendola C, Canfield M, Daiger SP , et al. Survival of Texas infants born with trisomies 21, 18, and 13. Am J Med Genet A 2010; 152A (2) 360-366